Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000900354 | SCV001044669 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001664537 | SCV001873746 | likely benign | not provided | 2021-02-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150370 | SCV003838868 | likely benign | Breast and/or ovarian cancer | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004017761 | SCV004849060 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-09-03 | criteria provided, single submitter | clinical testing | The c.1039-7A>T intronic alteration consists of a A to T substitution 7 nucleotides before coding exon 12 in the MLH1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |